CloserThe Closer Trial: A Multi-center, Prospective, Single Arm Trial to Evaluate the Safety and Efficacy of the Rex Medical Closer Vascular Sealing System (VSS) for the Management of the Femoral Arteriotomy After Percutaneous Endovascular Procedures
Closer VSS
Herida Quirúrgica
+ Heridas y Lesiones
Estudio de Tratamiento
Resumen
Fecha de inicio: 1 de mayo de 2014
Fecha en la que se inscribió al primer participante.The objective of the trial is to demonstrate the safety and effectiveness of the Rex Medical Closer Vascular Sealing System (VSS) in sealing femoral arterial access sites and providing reduced times to hemostasis (TTH) compared with performance goals at the completion of diagnostic or interventional procedures performed through 5, 6 or 7 Fr procedural sheaths. This study will be considered a success (from a statistical perspective) if it meets both the Closer VSS superiority goal for the primary effectiveness analysis and the Closer VSS performance goal for the primary safety analysis.
Protocolo
Esta sección proporciona detalles del plan del estudio, incluyendo cómo está diseñado y qué se está evaluando.Se reclutarán 220 pacientes
Número total de participantes que el ensayo clínico espera reclutar.Estudio de Tratamiento
Elegibilidad
Los investigadores buscan pacientes que cumplan ciertos criterios, conocidos como criterios de elegibilidad: estado general de salud o tratamientos previos.Cualquier sexo
Sexo biológico de los participantes elegibles para inscribirse.De 18 a 80 años
Rango de edades de los participantes que pueden unirse al estudio.Voluntarios sanos no permitidos
Indica si personas sanas, sin la condición que se estudia, pueden participar.Condiciones
Patología
Criterios
Inclusion Criteria: Pre-Op Inclusion Criteria: 1 - Acceptable candidates for an elective, non-emergent diagnostic or interventional endovascular procedure via the common femoral artery using a 5, 6, or 7 Fr introducer sheath. \- Exclusion Criteria: Pre-Operative Exclusion Criteria: 1. \- Significant bleeding diatheses or coagulopathy 2. \- Planned endovascular or surgical procedures within next 30 days 3. \- Planned ipsilateral femoral arteriotomy within next 90 days 4. \- Arteriotomy in ipsilateral groin within the past 30 days with any residual hematoma, significant bruising or vascular complication 5. \- Previous vessel closure device used in ipsilateral groin within the past 90 days 6. \- Previous vascular surgery or repair in the vicinity of the target access site 7. \- Severe peripheral vascular disease in the ipsilateral limb requiring surgical or endovascular treatment within the pervious 30 days or next 30 days 8. \- Existing nerve damage in ipsilateral limb 9. \- Extreme morbid obesity (BMI \> 4 kg/m2) Intra-operative Exclusion Criteria: 10. \- Use of a procedural sheath that is \< 5 Fr or \> 7 Fr 11. \- Difficult insertion of procedural sheath or needle stick problems at the onset of the procedure 12. \- Placement of an ipsilateral venous sheath for procedure 13. \- Procedural sheath placement either through the superficial femoral artery and into the profunda femoris artery, or placement at or distal to bifurcation of the superficial femoral artery and the profunda femoris artery 14. \- In subjects receiving unfractionated heparin, an ACT \> 350 seconds, or \> 250 seconds in the presence of a GP IIb/IIIa inhibitor 15. \- Procedures or existing medical conditions that may extend index hospitalization beyond 24 hours post-procedure 16. \- Systemic hypertension (SBP \> 180 mmHg) or hypotension (SBP \< 90 mmHg) just prior to enrollment
Plan de Estudio
Conoce todos los tratamientos administrados en este estudio, su descripción detallada y en qué consisten.Un solo grupo de intervención está designado en este estudio
0% de probabilidad de ser asignado al grupo placebo
Grupos de Tratamiento
Grupo I
ExperimentalObjetivos del Estudio
Objetivos Primarios
Objetivos Secundarios
Centros del Estudio
Estos son los hospitales, clínicas o centros de investigación donde se lleva a cabo el estudio. Puedes encontrar la ubicación más cercana a ti y su estado de reclutamiento.Este estudio tiene 12 ubicaciones
Colorado Neurological Institute
Englewood, United StatesWashington Hospital Center
Washington D.C., United StatesLafayette General Medical Center/Cardiovascular Institute of the South
Lafayette, United States